{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:46:18Z","timestamp":1770450378585,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":591,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Pediatric Oncology Foundation Groningen","award":["SKOG 11-001"],"award-info":[{"award-number":["SKOG 11-001"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajp.amjpathol.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ajpath.2018.01.018","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T17:25:13Z","timestamp":1518888313000},"page":"1289-1299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells"],"prefix":"10.1016","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7633-2114","authenticated-orcid":false,"given":"Agnieszka","family":"Dzikiewicz-Krawczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjan","family":"Diepstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bea","family":"Rutgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertrud","family":"Kortman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper","family":"Koerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Bulthuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tineke","family":"van der Sluis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaas","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Kluiver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8894-2638","authenticated-orcid":false,"given":"Anke","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2018.01.018_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.22719","article-title":"The non-Hodgkin lymphomas: a review of the epidemiologic literature","volume":"120 Suppl 12","author":"Alexander","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2018.01.018_bib2","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2018.01.018_bib3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt's lymphoma","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2018.01.018_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2018.01.018_bib5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1365-2141.2010.08111.x","article-title":"MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma","volume":"149","author":"Robertus","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajpath.2018.01.018_bib6","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1182\/blood-2010-10-315432","article-title":"Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway","volume":"117","author":"Bueno","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2018.01.018_bib7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2014-04-566778","article-title":"Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma","volume":"125","author":"Iqbal","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2018.01.018_bib8","doi-asserted-by":"crossref","first-page":"8185","DOI":"10.1073\/pnas.1322466111","article-title":"MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas","volume":"111","author":"Schneider","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2018.01.018_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.yexmp.2015.03.006","article-title":"Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis","volume":"98","author":"Robaina","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.ajpath.2018.01.018_bib10","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.18632\/oncotarget.6165","article-title":"Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma","volume":"7","author":"Slezak-Prochazka","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2018.01.018_bib11","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1182\/blood-2016-08-731166","article-title":"miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma","volume":"129","author":"Bartolome-Izquierdo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2018.01.018_bib12","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/leu.2017.94","article-title":"ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma","volume":"31","author":"Dzikiewicz-Krawczyk","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.ajpath.2018.01.018_bib13","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3324\/haematol.2016.143891","article-title":"Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis","volume":"101","author":"Hezaveh","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.ajpath.2018.01.018_bib14","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1093\/nar\/gkp715","article-title":"A high throughput experimental approach to identify miRNA targets in human cells","volume":"37","author":"Tan","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajpath.2018.01.018_bib15","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2018.01.018_bib16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ajpath.2017.02.016","article-title":"miR-24-3p is overexpressed in Hodgkin lymphoma and protects Hodgkin and Reed-Sternberg cells from apoptosis","volume":"187","author":"Yuan","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2018.01.018_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neo.2016.04.005","article-title":"Functional studies on primary tubular epithelial cells indicate a tumor suppressor role of SETD2 in clear cell renal cell carcinoma","volume":"18","author":"Li","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.ajpath.2018.01.018_bib18","series-title":"Lymphoma: Methods and Protocols","first-page":"265","article-title":"Studying MicroRNAs in lymphoma","author":"Kluiver","year":"2013"},{"key":"10.1016\/j.ajpath.2018.01.018_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ajpath.2018.01.018_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang da","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajpath.2018.01.018_bib21","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2018.01.018_bib22","doi-asserted-by":"crossref","first-page":"21629","DOI":"10.1073\/pnas.1016299107","article-title":"Dicer controls CD8+ T-cell activation, migration, and survival","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2018.01.018_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature07228","article-title":"Widespread changes in protein synthesis induced by microRNAs","volume":"455","author":"Selbach","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2018.01.018_bib24","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/gb-2014-15-3-r51","article-title":"Imperfect centered miRNA binding sites are common and can mediate repression of target mRNAs","volume":"15","author":"Martin","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.ajpath.2018.01.018_bib25","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3892\/ijo.2013.2034","article-title":"MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer","volume":"43","author":"Luo","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ajpath.2018.01.018_bib26","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1158\/0008-5472.CAN-06-4478","article-title":"Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia","volume":"67","author":"Landais","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2018.01.018_bib27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2018.01.018_bib28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00277-016-2653-7","article-title":"miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis","volume":"95","author":"Robaina","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ajpath.2018.01.018_bib29","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1038\/onc.2011.470","article-title":"Myc represses miR-15a\/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas","volume":"31","author":"Zhang","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2018.01.018_bib30","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1182\/blood-2008-03-147645","article-title":"MYC stimulates EZH2 expression by repression of its negative regulator miR-26a","volume":"112","author":"Sander","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2018.01.018_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.yexmp.2014.02.015","article-title":"Low expression of miR-150 in pediatric intestinal Burkitt lymphoma","volume":"96","author":"Wang","year":"2014","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.ajpath.2018.01.018_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/gcc.20273","article-title":"Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma","volume":"45","author":"Kluiver","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ajpath.2018.01.018_bib33","doi-asserted-by":"crossref","first-page":"e05005","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.ajpath.2018.01.018_bib34","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1074\/jbc.M608939200","article-title":"An E2F\/miR-20a autoregulatory feedback loop","volume":"282","author":"Sylvestre","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2018.01.018_bib35","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.molcel.2010.11.038","article-title":"The miR-17-92 microRNA cluster regulates multiple components of the TGF-\u03b2 pathway in neuroblastoma","volume":"40","author":"Mestdagh","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajpath.2018.01.018_bib36","doi-asserted-by":"crossref","first-page":"e00822","DOI":"10.7554\/eLife.00822","article-title":"A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis","volume":"2","author":"Olive","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.ajpath.2018.01.018_bib37","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1158\/0008-5472.CAN-10-2412","article-title":"The Myc\u2013miR-17\u223c92 axis blunts TGF\u03b2 signaling and production of multiple TGF\u03b2-dependent antiangiogenic factors","volume":"70","author":"Dews","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2018.01.018_bib38","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1101\/gad.1872909","article-title":"Genetic dissection of the miR-17\u223c92 cluster of microRNAs in Myc-induced B-cell lymphomas","volume":"23","author":"Mu","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2018.01.018_bib39","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1101\/gad.1861409","article-title":"miR-19 is a key oncogenic component of mir-17-92","volume":"23","author":"Olive","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2018.01.018_bib40","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1038\/emboj.2013.178","article-title":"MicroRNA-17\u223c92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways","volume":"32","author":"Jin","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.ajpath.2018.01.018_bib41","doi-asserted-by":"crossref","first-page":"e1002484","DOI":"10.1371\/journal.ppat.1002484","article-title":"The viral and cellular microRNA targetome in lymphoblastoid cell lines","volume":"8","author":"Skalsky","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ajpath.2018.01.018_bib42","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1074\/jbc.272.7.4230","article-title":"Involvement of p130Cas and p105HEF1, a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells","volume":"272","author":"Mani\u00e9","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2018.01.018_bib43","doi-asserted-by":"crossref","first-page":"18944","DOI":"10.1073\/pnas.1007558107","article-title":"SHEP1 partners with CasL to promote marginal zone B-cell maturation","volume":"107","author":"Browne","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2018.01.018_bib44","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.175.6.3492","article-title":"Crk-associated substrate lymphocyte type is required for lymphocyte trafficking and marginal zone B cell maintenance","volume":"175","author":"Seo","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2018.01.018_bib45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.gene.2009.01.020","article-title":"Histone acetyltransferase Hbo1: catalytic activity, cellular abundance, and links to primary cancers","volume":"436","author":"Iizuka","year":"2009","journal-title":"Gene"},{"key":"10.1016\/j.ajpath.2018.01.018_bib46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/MCB.00662-07","article-title":"Hbo1 links p53-dependent stress signaling to DNA replication licensing","volume":"28","author":"Iizuka","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2018.01.018_bib47","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/emboj.2012.63","article-title":"EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency","volume":"31","author":"Riley","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/j.ajpath.2018.01.018_bib48","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2018.01.018_bib49","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/labinvest.2009.26","article-title":"miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes","volume":"89","author":"Tan","year":"2009","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2018.01.018_bib50","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2008-09-178186","article-title":"Patterns of microRNA expression characterize stages of human B-cell differentiation","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017311768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017311768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T23:59:23Z","timestamp":1617235163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944017311768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0002944017311768"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2018.01.018","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2018.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}